Yara International ASA (YARIY) Q2 2025 Q&A Call Transcript

Yara International's Q2 2025 performance saw flat volume contribution to EBITDA, influenced by strong Q1 and ongoing asset optimization, which is also driving cost reductions into 2026. The company reaffirmed the viability of its U.S. blue ammonia projects, supported by maintained Section 45Q tax credits and a partnership-focused, no-equity-issuance funding strategy, despite CapEx inflation. Management addressed the new EU tariffs on Russian fertilizers, anticipating potential market shifts and higher prices, while noting the global fertilizer market remains tight for 2025 due to limited new capacity and strong demand. Yara is also implementing strict capital discipline, reducing its FY25 CapEx guidance by canceling growth projects that did not meet profitability targets and optimizing its asset footprint.

Analysis

Yara International's Q2 2025 earnings call highlighted a clear strategy centered on capital discipline and long-term growth projects. Management reduced its 2025 CapEx guidance, citing the cancellation of a growth project that failed to meet profitability thresholds, underscoring a stringent capital allocation policy. The company remains confident in its U.S. blue ammonia ambitions, clarifying that they are primarily supported by the Section 45Q tax credit, which was recently expanded and is less susceptible to political shifts than the broader Inflation Reduction Act. Yara plans to fund these projects via partnerships to share risk and leverage synergies, explicitly ruling out an equity issuance. On the market front, new EU import duties on Russian fertilizers are expected to level the competitive landscape, potentially shifting trade flows and supporting European prices, with ample alternative supply available from North Africa. While European volumes were weaker in Q2, this was attributed to a timing shift from a strong Q1, with total season deliveries up 1-2%. The global nitrogen market outlook for 2025-2026 remains tight due to limited new capacity, making Chinese export levels a critical variable and keeping urea prices firm in the $450-$500 range. Operationally, the company's cost-cutting program is ahead of its $30 million target for 2025 with further run-rate benefits expected in 2026, and NPK margins have remained approximately double their historical levels due to strong commercial execution.

Key Decisions for Investors

• Investors should monitor announcements regarding partnerships for the U.S. blue ammonia projects, as the no-equity-issuance funding strategy makes partner selection critical for de-risking and validating the long-term growth narrative.
• Given the tight global supply outlook and new EU tariffs on Russian product, consider the potential for sustained high fertilizer prices and strong NPK margins to support earnings and cash flow through 2026.
• It is prudent to factor in the positive financial impact of management's strict capital discipline, evidenced by lower CapEx guidance and an over-performing cost-reduction program, which should enhance returns on invested capital and free cash flow generation.